{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:16:02Z","timestamp":1790471762939,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.intimp.2014.05.005","type":"journal-article","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T18:00:13Z","timestamp":1400695213000},"page":"328-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Jignesh","family":"Nagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourabh","family":"Ranade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi","family":"Karunanithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva","family":"Subramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratika","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Dudhgaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeba Kannimel","family":"Vikramadithyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.05.005_bb0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","article-title":"Inflammatory bowel disease","volume":"28","author":"Kaser","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2014.05.005_bb0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nri2340","article-title":"The genetics and immunopathogenesis of inflammatory bowel disease","volume":"8","author":"Cho","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2014.05.005_bb0015","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1111\/j.1572-0241.2008.02158.x","article-title":"An update on the epidemiology of inflammatory bowel disease in Asia","volume":"103","author":"Thia","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.intimp.2014.05.005_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2014.05.005_bb0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.0105-2896.2005.00286.x","article-title":"Defects in mucosal immunity leading to ulcerative colitis","volume":"206","author":"Targan","year":"2005","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.intimp.2014.05.005_bb0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","article-title":"Microbial influences in inflammatory bowel diseases","volume":"134","author":"Sartor","year":"2008","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.intimp.2014.05.005_bb0035","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI200420295","article-title":"Bacterial flagellin is a dominant antigen in Crohn's disease","volume":"113","author":"Lodes","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2014.05.005_bb0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.immunol.021908.132657","article-title":"Regulatory lymphocytes and intestinal inflammation","volume":"27","author":"Izcue","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"10.1016\/j.intimp.2014.05.005_bb0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/1074-7613(94)90045-0","article-title":"Inhibition of Th1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45RBhi CD4+ T cells","volume":"1","author":"Powrie","year":"1994","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.intimp.2014.05.005_bb0050","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1084\/jem.188.10.1929","article-title":"Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4","volume":"188","author":"Boirivant","year":"1998","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.intimp.2014.05.005_bb0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2008.04.037","article-title":"TL1A(TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation","volume":"135","author":"Takedatsu","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.intimp.2014.05.005_bb0060","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/eji.1830260529","article-title":"Polyclonal expansion of adoptively transferred CD4+ \u03b1\u03b2 T cells in the colonic lamina propria of SCID mice with colitis","volume":"26","author":"Rudolphi","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2014.05.005_bb0065","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.intimp.2014.05.005_bb0070","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1182\/blood.V95.11.3460","article-title":"Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties","volume":"95","author":"Goldman","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2014.05.005_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09629359891090","article-title":"Intestinal permeability and contractility in murine colitis","volume":"7","author":"Meeteren","year":"1998","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.intimp.2014.05.005_bb0080","first-page":"566","article-title":"Inhibition by chloroquine of the class II histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding cell","volume":"80","author":"Lombard-Platelet","year":"1993","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2014.05.005_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2249.1995.tb06648.x","article-title":"Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness","volume":"102","author":"Landew\u00e9","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2014.05.005_bb0090","doi-asserted-by":"crossref","first-page":"e65913","DOI":"10.1371\/journal.pone.0065913","article-title":"Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis","volume":"8","author":"Thom\u00e9","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.intimp.2014.05.005_bb0095","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.intimp.2014.05.005_bb0100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1124\/jpet.112.200030","article-title":"Inhibition of Toll-like receptor-mediated inflammation in vitro and in vivo by a novel benzoxaborole","volume":"344","author":"Dong","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.intimp.2014.05.005_bb0105","doi-asserted-by":"crossref","first-page":"e13027","DOI":"10.1371\/journal.pone.0013027","article-title":"Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer","volume":"5","author":"Lowe","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2014.05.005_bb0110","doi-asserted-by":"crossref","first-page":"G1055","DOI":"10.1152\/ajpgi.00328.2004","article-title":"Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis","volume":"288","author":"Fukata","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"10.1016\/j.intimp.2014.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/gut.2009.205443","article-title":"Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis","volume":"59","author":"Sandborn","year":"2010","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2014.05.005_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.gastro.2012.04.010","article-title":"Abatacept for Crohn's disease and ulcerative colitis","volume":"143","author":"Sandborn","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.intimp.2014.05.005_bb0125","first-page":"917","article-title":"Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine","volume":"91","author":"Goenka","year":"1996","journal-title":"Am J Gastroenterol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T19:29:52Z","timestamp":1597865392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914001775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1567576914001775"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.05.005","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}